Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmen...
Evolutionary Genomics reported revenue of $0 for fiscal year 2022, and net income of -$2.25 million.
Figures from company filings; latest fiscal year ended December 31, 2022.
No profile data available.